When a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues.
Bu e-kitabı satın alın ve 1 tane daha ÜCRETSİZ kazanın!
Dil İngilizce ● Biçim PDF ● Sayfalar 496 ● ISBN 9781498718806 ● Editör Shein-Chung Chow & Dr. Paul Declerck ● Yayımcı CRC Press ● Yayınlanan 2017 ● İndirilebilir 3 kez ● Döviz EUR ● Kimlik 5364324 ● Kopya koruma Adobe DRM
DRM özellikli bir e-kitap okuyucu gerektirir